mrx0518 combination therapy meets primary efficacy endpoint ahead of enrollment completion
Published 2 years ago • 66 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
8:04
mrx0518 pembro in patients with resistance to therapy
-
1:38
future indications for mrx0518
-
1:12
reactivating antitumor efficacy of anti-pd-1 therapy with mrx0518
-
7:32
updates on mrx0518 pembro in patients with resistance to therapy
-
1:53
mrx0518 modification of solid tumor microenvironment
-
1:20
the nurse’s role in facilitating patient enrollment in clinical trials
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
0:26
using matchminer to improve clinical trial enrolment
-
0:56
meet internal medicine physician jeanette tetrault, md, facp, fasam
-
8:49
minority participation in breast cancer clinical trials
-
1:03
therapeutic plasma exchange in paediatric neurology | michael eyre | dmcn
-
3:58
preemptive therapy for cmv reactivation in hsct
-
1:36
medical device partnering program (mdpp) at flinders university
-
1:19
dr. bauml discusses a new electronic platform for clinical trial enrollment in lung cancer